REFERENCES

1. National Cancer Institute of Canada. Canadian Cancer Statistics 2000. Toronto, Canada, 2000.

2. Gaudette LA, Silberberger C, Altmayer CA, Gao RN. Trends in breast cancer incidence and mortality. Health Rep 1996;8:29-37.

3. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA 1995;273:149-54.

4. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 1993;85:1644-56.

5. The Workshop Group. Reducing deaths from breast cancer in Canada. Can Med Assoc J 1989;141:199-201.

6. Health Canada. Canadian Breast Cancer Initiative: National Committee for the Canadian Breast Cancer Screening Initiative. 1995 Summer.

7. Health Canada. Report on the National Forum on Breast Cancer. Minister of Supply and Services Canada, 1994. Cat. No. H39/305/994E.

8. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-209.

9. Europe Against Cancer. European guidelines for quality assurance in mammographic screening. Luxembourg: Office for Official Publications of the European Commission, June 1996.

10. Standards for the NHS Breast Screening Programme (updated August 1998). Sheffield, England: NHSBSP publication.

11. Muir Grey JA. A draft set of criteria for evaluation and quality assurance. NHSBSP, Oxford: Screening Publications, 1990.

12. Commonwealth Department of Human Services and Health. National program for the early detection of breast cancer: national accreditation requirements. Canberra, Australia: Commonwealth Department of Human Services and Health, March 1994.

13. Paquette D, Snider J, Bouchard F, Olivotto I, Bryant H, Decker K et al. for the Database Management Subcommittee to the National Committee for the Canadian Breast Cancer Screening Initiative. Performance of screening mammography in organized programs in Canada in 1996. Can Med Assoc J 2000;163:1133-38.

14. Working group on the integration of screening and diagnosis of the Canadian Breast Cancer Screening Initiative. Waiting for a diagnosis after an abnormal breast screen in Canada. 2000. Cat. No. H39-526(2000E).

15. Gaudette LA, Altmayer CA, Nobrega KM, Lee J. Trends in mammography utilization, 1981 to 1994. Health Rep 1996;8:17-27.

16. Faux AM, Lawrence GM, Wheaton ME, Wallis MG, Jeffery CL, Griffiths RK. Slippage in the NHS breast screening programme: an assessment of whether a three year screening round is being achieved. J Med Screen 1998;5:88-91.

17. Health Canada. Quality determinants of organized breast cancer screening programs. National Committee for the Canadian Breast Cancer Screening Initiative. 1997.

18. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected. Can Med Assoc J 1998;158(Suppl 3):S3-S8.

19. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Investigation of lesions detected by mammography. Can Med Assoc J 1998;158(Suppl 3):S9-S14.

20. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998;338:1089-96.

21. Olivotto IA, Mates D, Kan L, Fung J, Samant R, Warren Burhenne LJ. Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia. Breast Cancer Research and Treatment 1999;54:73-81.

22. Caines JS, Chantziantoniou K, Wright BA, Konok GP, Iles SE, Bodurtha A et al. Nova Scotia Breast Screening Program experience: Use of needle core biopsy in the diagnosis of screening-detected abnormalities. Radiology 1996;198:125-30.

23. Day NE, Williams DRR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989;59:954-58.

24. Woodman CB, Threlfall AG, Boggis CR, Prior P. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. Brit Med J 1995;310:224-26.

25. Rickard MT, Taylor RJ, Fazli MA, El Hassan N. Interval breast cancers in an Australian mammographic screening program. Med J Aust 1998;169:184-87.

26. Faux AM, Richardson DC, Lawrence GM, Wheaton ME, Wallis MG. Interval breast cancers in the NHS Breast Screening Programme: does the current definition exclude too many? J Med Screen 1997;4:169-73.

[Previous] [Table of Contents] [Next]